| dc.contributor.author |
Butnev, Vladimir Y. |
en_US |
| dc.contributor.author |
Singh, V. |
en_US |
| dc.contributor.author |
Nguyen, Van T. |
en_US |
| dc.contributor.author |
Bousfield, George R. |
en_US |
| dc.date.accessioned |
2012-01-24T17:48:25Z |
|
| dc.date.available |
2012-01-24T17:48:25Z |
|
| dc.date.issued |
2002-03 |
en_US |
| dc.identifier |
11874703 |
en_US |
| dc.identifier |
AG15428/ DK52383 |
en_US |
| dc.identifier |
0375363 |
en_US |
| dc.identifier |
JOE04323 |
en_US |
| dc.identifier.citation |
The Journal of endocrinology. 2002 Mar; 172(3): 545-55. |
en_US |
| dc.identifier.issn |
0022-0795 |
en_US |
| dc.identifier.uri |
http://dx.doi.org/10.1677/joe.0.1720545 |
|
| dc.identifier.uri |
http://hdl.handle.net/10057/4123 |
|
| dc.description |
Click on the DOI link below to access the article (may not be free). |
en_US |
| dc.description.abstract |
Hybrid hormone preparations were prepared by combining intact and Asn(56)-deglycosylated (N(56)dg) equine (e) LH or FSH alpha subunit preparations with truncated, des(121-149)eLH beta (eLH beta t), immunopurified, intact eLH beta or equine chorionic gonadotropin beta (eCG beta) preparations, and eFSH beta. The LH receptor-binding potencies of N(56)dg-eLH alpha:eLH beta t and N(56)dg-eFSH alpha:eLH beta t hybrids were equivalent to that of eLH; however, both N(56)dg-alpha preparations were only 3-4% as active as eLH in the rat testis Leydig cell bioassay. In the granulosa cell FSH bioassay, eLH alpha:eLH beta t stimulated progesterone synthesis and induced aromatase activity, while N(56)dg-eLH alpha:eLH beta t was completely inactive at doses up to 5 microg. N(56)dg-eLH alpha:eLH beta t inhibited progesterone production and aromatase induction elicited by 0.3 ng eFSH or 2 ng human (h) FSH. The inhibitory activities of N(56)dg-eLH alpha:eLH beta and N(56)dg-eCG alpha:eLH beta t were only 10% that of N(56)dg-eLH alpha:eLH beta t. N(56)dg-eLH alpha:eCG beta did not inhibit progesterone synthesis stimulated by eFSH at all and appeared to further stimulate aromatase induction at the highest dose tested. Preincubation of N(56)dg-eLH alpha:eLH beta and N(56)dg-eLH alpha:eLH beta t for 72 h at 37 C resulted in no loss of FSH receptor-binding activity. Preincubation resulted in 50% loss of receptor-binding activity by the eFSH preparation due to subunit dissociation, while 88% of N(56)dg-eLH alpha:eFSH beta activity was lost following 72 h, 37 C preincubation. While alpha Asn(56) oligosaccharide had no effect on eLH beta hybrid stability, it did contribute to the stability of the eFSH heterodimer. |
en_US |
| dc.description.sponsorship |
NIA NIH HHS/ NIDDK NIH HHS |
en_US |
| dc.language.iso |
eng |
en_US |
| dc.publisher |
BioScientifica Ltd. |
en_US |
| dc.relation.ispartofseries |
The Journal of endocrinology |
en_US |
| dc.source |
NLM |
en_US |
| dc.subject |
Research Support, U.S. Gov't, Non-P.H.S. |
en_US |
| dc.subject |
Research Support, U.S. Gov't, P.H.S. |
en_US |
| dc.subject.mesh |
Animals |
en_US |
| dc.subject.mesh |
Dimerization |
en_US |
| dc.subject.mesh |
Dose-Response Relationship, Drug |
en_US |
| dc.subject.mesh |
Female |
en_US |
| dc.subject.mesh |
Follicle Stimulating Hormone/antagonists & inhibitors |
en_US |
| dc.subject.mesh |
Glycoprotein Hormones, alpha Subunit/metabolism |
en_US |
| dc.subject.mesh |
Granulosa Cells/drug effects |
en_US |
| dc.subject.mesh |
Horses |
en_US |
| dc.subject.mesh |
Luteinizing Hormone/chemistry |
en_US |
| dc.subject.mesh |
Radioligand Assay/methods |
en_US |
| dc.subject.mesh |
Rats |
en_US |
| dc.subject.mesh |
Recombinant Proteins/metabolism |
en_US |
| dc.subject.mesh |
Glycoprotein Hormones, alpha Subunit/metabolism |
en_US |
| dc.subject.mesh |
Granulosa Cells/metabolism |
en_US |
| dc.subject.mesh |
Luteinizing Hormone/metabolism* |
en_US |
| dc.title |
Truncated equine LH beta and asparagine(56)-deglycosylated equine LH alpha combine to produce a potent FSH antagonist |
en_US |
| dc.type |
Article |
en_US |
| dc.description.version |
peer reviewed |
en_US |
| dc.rights.holder |
Copyright @ 2002 Society for Endocrinology |
en_US |